Aspirin after kidney stone treatment to prevent clotting
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at whether taking a daily aspirin medicine during and after extracorporeal shockwave treatment for a kidney stone helps keep the blood from “clumping” too much. It will compare different maintenance approaches while monitoring safety, especially bleeding risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old
- You have at least one kidney stone that needs shockwave treatment (extracorporeal lithotripsy)
- You are currently taking Kardégic 75 (aspirin) as your only blood-thinning/anti-clotting medicine
- You do NOT have a known bleeding disorder (now or in the past)
- You are NOT taking any other blood thinners or anti-platelet medicines (such as warfarin, rivaroxaban/apixaban, heparin, or P2Y12 drugs)
- You can’t have a planned need for more than one shockwave session during the study period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests whether taking an anti-inflammatory medicine around the time of ureter stent placement can improve outcomes for people with kidney stones. It looks for participants who are getting a stent after a scope procedure and who can follow strict medication and health rules.
This trial compares two timing schedules for using shock waves to break up small kidney stones that remain after a surgical procedure. The goal is to find the best time to treat these leftover stones to help them pass naturally and prevent complications.
This study checks how aspirin (also called salicylate) affects how platelets work, which helps blood clot. It involves people with advanced chronic kidney disease who are treated with Aranesp, and it may help guide safer care.
This trial studies whether kidney-stone shockwave treatment works better when you lie on your back (supine) versus on your stomach (prone). It focuses on adults with a stone in the lower part of the urine tube (the distal ureter).
This study compares two ways of delivering sound wave therapy (ESWL) to break up kidney or ureter stones. One approach gradually increases the energy, while the other uses a fixed level, and the goal is to see which is more effective and comfortable for patients like you.
This trial compares a natural anti-inflammatory supplement called PEA to a common painkiller (ibuprofen) for managing pain after a procedure that breaks up kidney stones with sound waves. The goal is to see if PEA works as well as ibuprofen but with fewer side effects.
Hear when a new Hematoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.